Results 301 to 310 of about 54,096 (328)
Some of the next articles are maybe not open access.

Idiopathic Myelofibrosis

Seminars in Hematology, 2005
Idiopathic myelofibrosis (IMF) is characterized by anemia, progressive splenomegaly, bone marrow fibrosis, and extramedullary hematopoiesis. However, patients with a transitional myeloproliferative disorder (MPD), a prefibrotic form of myelofibrosis, or myelofibrosis with a fatty bone marrow share many features of IMF but have clinical characteristics ...
Giovanni, Barosi, Ronald, Hoffman
openaire   +2 more sources

Chromosome Abnormalities in Myelofibrosis [PDF]

open access: possibleActa Haematologica, 1987
Cytogenetic analysis was performed on megakaryocyte-enriched cell fractions obtained by separation on discontinuous Percoll gradients from blood, bone marrow, and ascitic fluid of 12 patients with myelofibrosis with myeloid metaplasia (MMM). The most common abnormalities appeared to involve chromosomes 1, 3, 7, 8, 11, 13, 21 and 22.
Paolo Tomasi   +3 more
openaire   +2 more sources

Myelofibrosis and benzene exposure [PDF]

open access: possibleOccupational Medicine, 1995
Petrol station attendants are exposed to benzene, a well-known carcinogen for blood malignancies. A case of myelofibrosis in a petrol station attendant is presented, along with other reports of myelofibrosis after benzene exposure obtained from the Swedish Cancer Environment Register.
John Carstensen   +2 more
openaire   +2 more sources

Differential diagnosis of myelofibrosis based on WHO 2008 criteria: Acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis

International Journal of Laboratory Hematology, 2013
SummaryIntroductionThe aim of this study was to characterize clinicopathological features of acute panmyelosis with myelofibrosis (APMF), acute megakaryoblastic leukemia with myelofibrosis (AMKL‐MF), primary myelofibrosis (PMF) and myelodysplastic syndrome with myelofibrosis (MDS‐MF) in order to provide the keys to the differential diagnosis of bone ...
E, Bae   +10 more
openaire   +3 more sources

Romiplostim-induced myelofibrosis

Blood, 2013
![Figure][1] A 55-year-old woman with chronic refractory idiopathic thrombocytopenic purpura (ITP) presented with gum bleeding for 1 day. Over the course of several years, she had failed, or became resistant to, multiple treatments including glucocorticoids, intravenous immunoglobulin,
Michele R. Roullet, Armin Rashidi
openaire   +3 more sources

Acute Myelofibrosis

American Journal of Clinical Pathology, 1982
This report describes a 20-year-old patient with rapidly fatal fibrosis of the bone marrow associated with leukopenia, anemia, and large number of myeloblasts in peripheral blood. The bone marrow revealed extensive fibrosis and hyperplasia of the myeloblasts and megakaryocytes.
openaire   +2 more sources

The ABCCs of myelofibrosis [PDF]

open access: possibleBlood, 2005
Comment on Barosi et al, page [2849][1] “The illness which he'd been smitten should have been analyzed when caught something like spleen that scourge of Britain or Russia's chondria for short” —Alexander Pushkin Eugene Onegin (1823), stanza 38 For nearly 150 years, the ...
openaire   +1 more source

Pyoderma gangrenosum with myelofibrosis

The American Journal of Medicine, 1987
Pyoderma gangrenosum is a papulovesicular skin disorder commonly associated with underlying systemic disease, but rarely with the myeloproliferative syndromes. A case of rapidly progressive pyoderma is cited in a 77-year-old white man who had no other evidence of disease aside from macrocytic anemia.
Frank J. Kroboth   +2 more
openaire   +3 more sources

Therapeutic approaches in myelofibrosis

Expert Opinion on Pharmacotherapy, 2011
Myeloproliferative neoplasm (MPN)-associated myelofibrosis is the most disabling of the classical Philadelphia-negative MPNs. The discovery that a gain-of-function mutation of JAK2 (JAK2V617F) is present in more than 60% of patients with MPN-associated myelofibrosis has provided a new target for innovative treatment strategies.This review discusses the
G. Barosi   +2 more
openaire   +4 more sources

Myelofibrosis in Young Adults

Acta Haematologica, 1983
3 young adults with myelofibrosis, a rare disease in this age-group, are presented. Their clinical course was distinguished by a virtually asymptomatic state at time of diagnosis and a stable, or very slowly progressive course over a 4- to 5-year follow-up.
Oded Shalev   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy